b.value AG — Deutsche Biotechnologie Beteiligungsaktiengesellschaft
As one of the first German biotechnology investment companies, b.value AG aims to fully develop the economic potential of bio-based technologies from the fields of industrial biotechnology, life science and chemistry in the common interest of founders and investors. Operationally active since 2017, b.value AG invests in seed stage companies in German-speaking countries as a minority and majority stakeholder in almost all cases together with other co-investors.
To cope with the diversity and complexity of the science-driven and high-tech sector, the operational b.value team is characterized by an extraordinary technological specialization and combines in its management more than 40 years of leadership experience in the development of technology companies as well as the commercialization of biotechnological developments. In addition to the high level of specialization and a deep understanding of the industry, the portfolio companies benefit from b.value’s unique “company-building” approach as well as a wide network of scientists, executives, policy makers and industrial and academic thought leaders.